Image-guided therapy developer IMRIS has received the CE Mark for integration of the next generation of its core MRI technology into its Visius Surgical Theatre.
The new imaging technology, based on Siemens Healthcare's Aera 1.5-tesla and Skyra 3-tesla MRI scanners, is designed to improve image quality, 3D image acquisition, and workflow during surgical procedures using intraoperative MRI.
IMRIS received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the upgrades in February.
